联泰环保(603797) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was CNY 349,490,397.55, representing a 19.10% increase compared to CNY 293,443,600.99 in the same period last year[2] - The net profit attributable to shareholders decreased by 9.19% to CNY 62,959,001.74 from CNY 69,328,993.03 year-on-year[2] - The net profit after deducting non-recurring gains and losses was CNY 60,985,957.38, down 9.33% from CNY 67,260,259.15 in the previous year[2] - The basic earnings per share for Q1 2023 was CNY 0.11, a decrease of 8.33% from CNY 0.12 in the same period last year[4] - Net profit for Q1 2023 was CNY 66,374,016.18, a decrease of 11.9% from CNY 75,339,343.01 in Q1 2022[37] Assets and Liabilities - Total assets at the end of Q1 2023 amounted to CNY 10,288,883,141.98, reflecting a 0.77% increase from CNY 10,253,008,592.63 at the end of the previous year[4] - The total liabilities decreased to CNY 7,124,584,464.06 from CNY 7,249,236,721.58, a reduction of CNY 124,652,257.52[7] - Total liabilities increased to CNY 7,260,001,523.65 from CNY 7,249,236,721.58, indicating a rise of 0.1%[34] - As of March 31, 2023, the company's total current assets amounted to RMB 1,741,094,841.49, an increase from RMB 1,689,708,617.40 at the end of 2022, reflecting a growth of approximately 3.0%[30] Cash Flow - The net cash flow from operating activities was negative at CNY -34,335,920.01, an improvement from CNY -93,614,066.13 in the same period last year[2] - The company's cash flow from operating activities for Q1 2023 showed a significant increase, reflecting improved operational efficiency[40] - In Q1 2023, the cash inflow from operating activities was CNY 262,840,888.44, an increase of 7.3% compared to CNY 244,333,441.93 in Q1 2022[43] - The net cash flow from financing activities decreased by 117.07%, reflecting a reduction in bank loan funding compared to the same period last year[19] - The total cash and cash equivalents at the end of Q1 2023 were CNY 489,531,384.60, down from CNY 945,821,216.83 at the end of Q1 2022[45] Investments and Acquisitions - The company completed the acquisition of 100% equity in Shenzhen Lian Tai Industrial Development Co., Ltd. for a total cash consideration of CNY 85,213,600[5] - The company also acquired stakes in Shantou Tianhui Health Biotechnology Co., Ltd. for a total of RMB 8,521,360[26] - The company raised approximately ¥1.37 billion through borrowings, which is an increase of ¥40 million compared to the previous period[15] Operating Costs and Expenses - Operating costs for Q1 2023 were CNY 265,670,666.19, up from CNY 211,362,606.84 in Q1 2022, reflecting a growth of 25.7%[35] - Operating costs rose by 33.26%, primarily due to the operational costs associated with the Shantou West District project and increased costs from higher sales of industrial-grade mixed oil[19] - Research and development expenses for Q1 2023 were CNY 1,769,265.16, up from CNY 1,390,352.18 in Q1 2022, indicating a focus on innovation[37] - The company incurred CNY 71,566,100.18 in other operating cash payments, a significant increase from CNY 15,409,606.91 in the same quarter last year[43] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 18,517[21] - The largest shareholder, Guangdong Lian Tai Group Co., Ltd., holds 44.60% of the shares, amounting to 260,517,371 shares[22] Other Income and Expenses - The company reported a significant increase in other income, which rose to approximately ¥40.02 million, up from ¥14.77 million, representing a growth of 170.5%[10] - Other income grew by 45.85%, mainly due to an increase in VAT input tax credits compared to the previous year[19] - The company recorded a total of 4,040,102.11 in government subsidies recognized in the current period, closely related to normal business operations[17]